ARTICLE | Company News
Lophius Biosciences neurology news
June 24, 2013 7:00 AM UTC
Lophius joined the NEU2 consortium with a two-year project to develop the T-Track MS as a blood-based diagnostic test to support the initial diagnosis of multiple sclerosis and enable monitoring of disease progression. The project has more than €350,000 ($466,515) in funding from Germany's Federal Ministry of Education and Research (BMBF). The T-Track MS test is a T cell-based diagnostic. ...